clinical trial · NCT06161584
A Prospective, Multicenter, Open-Label, Observational Phase 4 Study to Evaluate Real-World Safety, Tolerability, and Treatment Patterns of Pegcetacoplan (Syfovre) in Patients With Geographic Atrophy Secondary to Age-Related Macular Degeneration
Geographic AtrophyPegcetacoplan
brief summary
A Prospective, Multicenter, Open-Label, Observational Phase 4 Study to Evaluate Real-World Safety, Tolerability, and Treatment Patterns of Pegcetacoplan (Syfovre) in Patients with Geographic Atrophy Secondary to Age-Related Macular Degeneration
started
Sep 28, 2023
primary completion
Jun 1, 2027
completion
Jun 1, 2027
last updated
Mar 6, 2026
sourced from ClinicalTrials.gov · pharmadog mirrors structured fields, not the full protocol